Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Voacanga africana
West African tree; source of ibogaine precursor voacangine; used in traditional medicine for stimulation.
Voacanga africana is a West African tree whose bark and seeds contain indole alkaloids including voacangine, voacamine, and tabersonine, which are precursors to ibogaine. Traditionally used as a stimulant and in ceremonial contexts, it has been investigated for antiviral and analgesic properties. However, its narrow therapeutic index and risk of cardiac toxicity and psychoactive effects preclude self-medication.
The primary alkaloids, voacangine and voacamine, act as serotonin 5-HT2A receptor partial agonists and sigma-1 receptor ligands, similar to ibogaine. They also inhibit the reuptake of serotonin and dopamine, contributing to stimulant and psychoactive effects. Voacangine is metabolized to ibogaine via O-demethylation, which may account for its anti-addictive potential. Additionally, these compounds interact with opioid receptors and sodium channels, providing analgesic and antiarrhythmic actions, though the latter can be proarrhythmic at high doses.
West African tree; source of ibogaine precursor voacangine; used in traditional medicine for stimulation.
Voacanga africana is a West African tree whose bark and seeds contain indole alkaloids including voacangine, voacamine, and tabersonine, which are precursors to ibogaine. Traditionally used as a stimulant and in ceremonial contexts, it has been investigated for antiviral and analgesic properties. However, its narrow therapeutic index and risk of cardiac toxicity and psychoactive effects preclude self-medication.
The primary alkaloids, voacangine and voacamine, act as serotonin 5-HT2A receptor partial agonists and sigma-1 receptor ligands, similar to ibogaine. They also inhibit the reuptake of serotonin and dopamine, contributing to stimulant and psychoactive effects. Voacangine is metabolized to ibogaine via O-demethylation, which may account for its anti-addictive potential. Additionally, these compounds interact with opioid receptors and sodium channels, providing analgesic and antiarrhythmic actions, though the latter can be proarrhythmic at high doses.